Bios Capital Management, LP In8 Bio, Inc. Transaction History

Bios Capital Management, LP

  • $72.6 Billion
  • Q2 2025

A detailed history of Bios Capital Management, LP transactions in In8 Bio, Inc. stock. As of the latest transaction made, Bios Capital Management, LP holds 286,664 shares of INAB stock, worth $644,994. This represents 0.83% of its overall portfolio holdings.

Number of Shares
286,664
Previous 8,600,001 96.67%
Holding current value
$644,994
Previous $1.43 Billion 58.03%
% of portfolio
0.83%
Previous 1.8%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$0.12 - $4.17 $997,600 - $34.7 Million
-8,313,337 Reduced 96.67%
286,664 $599 Million
Q4 2024

Feb 10, 2025
BUY
$0.23 - $0.48 $1.98 Million - $4.13 Million
8,600,001 New
8,600,001 $2.21 Billion

Others Institutions Holding INAB

# of Institutions
11
Shares Held
2.63M
Call Options Held
0
Put Options Held
0
View Full List

About IN8BIO, INC.

INAB Quotes by TradingView
  • Ticker INAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,502,200
  • Market Cap $55.1M
  • Description
  • IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...
More about INAB
Track This Portfolio

Track Bios Capital Management, LP Portfolio

Follow Bios Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bios Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bios Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email